Patents by Inventor Blair Ardman

Blair Ardman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6997863
    Abstract: Disclosed are therapeutic methods for the treatment of disease material involving administration of a thermotherapeutic magnetic composition, which contains single-domain magnetic particles attached to a target-specific ligand, to a patient and application of an alternating magnetic field to inductively heat the thermotherapeutic magnetic composition. Also disclosed are methods of administering the thermotherapeutic magnetic material composition. The thermotherapeutic methods may be used where the predetermined target is associated with diseases, such as cancer, diseases of the immune system, and pathogen-borne diseases, and undesirable targets, such as toxins, reactions associated with organ transplants, hormone-related diseases, and non-cancerous diseased cells or tissue.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: February 14, 2006
    Assignee: Triton BioSystems, Inc.
    Inventors: Erik S. Handy, Robert Ivkov, Diane Ellis-Busby, Allan Foreman, Susan J. Braunhut, Douglas U. Gwost, Blair Ardman
  • Publication number: 20030032995
    Abstract: Disclosed are therapeutic methods for the treatment of disease material involving administration of a thermotherapeutic magnetic composition, which contains single-domain magnetic particles attached to a target-specific ligand, to a patient and application of an alternating magnetic field to inductively heat the thermotherapeutic magnetic composition. Also disclosed are methods of administering the thermotherapeutic magnetic material composition. The thermotherapeutic methods may be used where the predetermined target is associated with diseases, such as cancer, diseases of the immune system, and pathogen-borne diseases, and undesirable targets, such as toxins, reactions associated with organ transplants, hormone-related diseases, and non-cancerous diseased cells or tissue.
    Type: Application
    Filed: July 19, 2002
    Publication date: February 13, 2003
    Applicant: Triton Biosystems, Inc.
    Inventors: Erik S. Handy, Robert Ivkov, Diane Ellis-Busby, Allan Foreman, Susan J. Braunhut, Douglas U. Gwost, Blair Ardman
  • Patent number: 5252556
    Abstract: A fragment capable of binding to an anti-CD43 autoantibody made by a human infected with HIV-1. The fragment, which includes a part or the entirety of an amino acid sequence corresponding to positions 20-254 of CD43, can be used in treatment or diagnosis of HIV-1 infections.
    Type: Grant
    Filed: March 30, 1990
    Date of Patent: October 12, 1993
    Assignee: New England Medical Center Hospitals, Inc.
    Inventor: Blair Ardman